Source: Senegal, Project Optimize, 2012

Certains coûts liés aux vaccins sont cachés

some Vaccine costs are hidden beloW the surface

Vaccine WastagePerte en vaccin

Expédition internationale, importation, manutention

Main d’œuvre

Alimentation del’équipement de la chaîne du froid en énergie

Coût du carburant des véhicules

Transport (gestion de la location de véhicules)

Entretien/maintenance de l’équipement de la chaîne du froid et infrastructure

Dépréciation des véhicules

Achat de boîtes de sécurité

et seringues, et élimination des déchets

Prix du vaccin

international shipment, import,

handling

laborsyringe and safety box

purchase and Waste disposal

cold chain eQuipment

depreciation

Vehicle depreciation

cold chain eQuipment energy

Vehicle fuel costs

cold chain maintenance, infrastructure

transport (rental, handling)

Vaccine price

Dépréciation de l’équipement de la chaîne du froid

VACCINE PRESENTATION CHOICES

What you should know about vaccine choices:

Not all vaccine presentations are alike. Each product presents trade-offs that need to be considered in the context of different countries.

It is critical for a national decision-maker to understand his or her country’s unique situation and the objectives of the program, along with the vaccination strategy being used in order to select a presentation that is likely to be most successful in that context.

Vaccine purchase price per dose is not necessarily a good predictor of total cost per dose delivered. An expensive vaccine presentation might end up costing less per dose delivered than an inexpensive presentation when all the delivery costs are taken into account.

There are many factors that go into total cost per dose delivered, including: packaging size for cold chain transport and storage; number of product components that must be ordered, stored, and transported; product complexity and resulting training and supervision needs; health worker time needed to prepare the vaccine; and whether or not the vaccine can be kept for more than one session after the container is opened.

There is no one “right choice”— this will vary by country, strategy and situation. It is important to take all these factors into consideration when making a vaccine product choice.

O P T I M I Z E Immunization systems and technologies for tomorrow

EXHIBITO P T I M I Z E Immunization systems and technologies for tomorrowVACCINE PRESENTATION CHOICES

R E S O U R C E T Y P E T I T L E O R G A N I Z A T I O N

Product profilesGeneric preferred product profiles for vaccine destined for use in developing countriesAVAILABLE AT: www.path.org/vaccineresources/details.php?i=1149OR: www.who.int/immunization_delivery/systems_policy/vppag/

Vaccine Presentation and Packaging Advisory Group

ArticleVaccine Presentation and Packaging Advisory Group: a forum for reaching consensus on vaccine product attributes AVAILABLE AT: www.who.int/bulletin/volumes/91/1/12-110700/en/index.html

Bulletin of the World Health Organization

Website Immunization policies and recommendationsAVAILABLE AT: www.who.int/immunization/policy/en/

World Health Organization

ArticleDesigning vaccines for developing-country populations; ideal attributes, delivery devices, and presentation formatsAVAILABLE AT: www.sciencedirect.com/science/article/pii/S1877282X10000251

Science Direct

DocumentAssessing the Programmatic Suitability of Vaccine Candidates for WHO Prequalification, WHO/IVB/12.10AVAILABLE AT: www.who.int/immunization_standards/vaccine_quality/ps_pq/en/

World Health Organization

DocumentThe Right Shot: Extending the Reach of Affordable and Adapted VaccinesAVAILABLE AT: www.msfaccess.org/content/rightshot

Doctors Without Borders

Vaccine Presentation and Packaging Advisory Group sites.google.com/site/vppagp/

TechNet-21 www.TechNet-21.org

PATH sites.path.org/

WHO www.who.int/immunization

Immunization Practices Advisory Committee at WHO www.who.int/immunization_delivery/ systems_policy/ipac/en/index.html

UNICEF www.unicef.org/immunization

UNICEF Supply Division www.unicef.org/supply/

International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)

www.ifpma.org/

Developing Country Vaccine Manufacturers Network (DCVMN)

www.dcvmn.org/

Maternal and Child Health Integrated Program (MCHIP) www.mchip.net/

US Centers for Disease Control (CDC) www.cdc.gov/globalhealth/gid/

GAVI Alliance www.gavialliance.org/

The Bill & Melinda Gates Foundation www.gatesfoundation.org/

V3P Project (Product, Price, and Procurement) www.who.int/immunization_supply/ procurement/v3p/en/index.html

Doctors Without Borders www.doctorswithoutborders.org

WEBSITES OF ORGANIZATIONS AND GROUPS WORKING ON THIS ISSUE

RELEVANT RESOURCES

August 2013